Churg-Strauss vasculitis in patient who received montelukas
Introduction. Montelukast is a selective leukotriene receptor antagonist. One of side effects of this drug class is the Churg-Strauss syndrome (CSS). There is still no reliable evidence whether the expression of this syndrome could be masked by high doses of corticosteroids and become expressed by t...
Saved in:
| Main Authors: | Ćupurdija Vojislav, Čekerevac Ivan, Petrović Marina, Kostić Gordana, Suša Romana, Lazić Zorica |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade
2018-01-01
|
| Series: | Vojnosanitetski Pregled |
| Subjects: | |
| Online Access: | http://www.doiserbia.nb.rs/img/doi/0042-8450/2018/0042-84501600351C.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Churg-Strauss Síndrome. A presentation of two cases
by: Julio López Argüelles, et al.
Published: (2010-12-01) -
Churg-Strauss syndrome: A case report
by: Dinić Miroslav Ž., et al.
Published: (2013-01-01) -
The Impact of Churg–Strauss Syndrome on Nasal Function and Quality of Life: An Underexplored Dimension
by: Luca Galassi, et al.
Published: (2025-01-01) -
Peripheral neuropathy as initial manifestation of Churg-Strauss Syndrome
by: Antonio Villa, et al.
Published: (2020-03-01) -
Churg-Strauss syndrome
by: Ilić Tatjana, et al.
Published: (2002-01-01)